Loading clinical trials...
Loading clinical trials...
Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received European Union (EU) -Approved COVID-19 Vaccines
Patients who voluntarily visit vaccination centers in Greece against COVID-19 are recruited and their immunization levels against Sars-Cov2 are assesed by measurement of the levels of serum antibodies against Sars-cov-2 before vaccination and in time intervals up to 6-9 months post-vaccination (indicatively 0-1-3-6-9 months post-vaccination).
Age
All ages
Sex
ALL
Healthy Volunteers
No
University Hospital of Patras
Pátrai, Greece
Start Date
July 7, 2021
Primary Completion Date
March 28, 2022
Completion Date
March 28, 2022
Last Updated
June 6, 2022
1,000
ACTUAL participants
Approved vaccines against Sars-Cov2
BIOLOGICAL
Lead Sponsor
University of Patras
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions